Frequently Asked Questions

The study drug may have side effects that are explained to you during your medical visit. However, it is important to mention that the majority of side effects are short-lived and it is the participant’s responsibility to report any new adverse events. 

The trials are supervised by qualified, trained and experienced doctors, nurses and technicians who follow rigorous procedures. At all times, day and night, you will be supervised by our staff who will be happy to answer all your questions and respond to all your needs. 

No. The amount of the compensation is not determined by the potential risks associated with the study, but is determined by the inconvenience of the study, such as the time spent on our premises and the frequency of visits. In some cases, these may be inconveniences related to restrictions during the study or to a large number of samples taken during the night. 

The amounts indicated represent the compensation paid if the study is completed by the participant. If the participant decides to withdraw from the study on their own before the end, they will receive only an amount proportional to the time invested. 

In most cases, most of the amount is paid at the end of the study directly to the participant on a ClinCard. On the other hand, if the study lasts several months, the distribution of the allowance may change. Everything is explained during your visit to our premises. 

The vast majority of our studies require confinement, which means that participants have to sleep in our clinic. However, some studies may not require confinement. 

Participants can participate in several studies, but not at the same time. You must complete a waiting period between studies (usually between 30 and 56 days) to ensure your safety. 

All stays must be completed at our Quebec City Clinic located in the Quebec Metro High Tech Park. We also have a site in Montreal for return visits or physical exams. We also offer a shuttle service between our Montreal and Quebec City sites for confinement in Quebec City. Depending on the study, we reserve the right to limit certain participations. 

To limit the inconvenience, participants who live more than 90 minutes from our clinics (Quebec and Montreal) cannot participate in our studies. 

You could be eligible, depending on several factors, such as the type of cancer and number of years without recurrence. Each case is assessed by our doctors. 

It is very important to control the environment for this type of research. Therefore, if the protocol requires it, you will have to stay in our clinic for the duration of the study, although this rarely lasts longer than 36 hours. For stays longer than 72 hours, outings take place under the supervision of our staff. 

You will be informed of the required conditions before giving your consent to participate. However, participants can withdraw from the study at any time and have the opportunity to leave. In that case, a doctor will assess the risks of leaving the clinic early. For safety reasons, we recommend that participants follow the doctor’s advice.

Participants sleep in dormitories or bunk rooms with a maximum of 8 people. In mixed studies, where study activities permit, we are careful to separate men from women. 

Bring your personal belongings, clothes, books, magazines, laptop, etc. No products that may contain medicinal ingredients should be brought. In addition, according to the study, some personal belongings could be set aside to avoid interactions with the study drug. Soap, shampoo, towels and bedding are provided. You cannot bring extra bedding. Showers are also available. 

We pay special attention to your personal information to ensure confidentiality. Your personal information such as your name, address, phone number or email address will be kept confidential except when required by law. Inside Syneos HealthTM, you will always be identified by a code that does not reveal your identity.